Targeted Protein Degradation PlatformChemicals ResearchUpdated on Jul 30, 2019 View more like this | Visit SHIRLEY, NY | Contact BOCSCI INC |
BOC Sciences provides a range of Protein Degraders (PROTAC molecules) targeting various protein targets, as well as Degrader Building Blocks, linkers and peptides to support TPD research and development.
While PROTAC technology has been a rising star in drug development in recent years, the technique is still facing some issues caused by relatively with high molecular weight, stability, toxicity, pharmacokinetics and bioavailability. By overcoming these limitations, PROTACs could be eventually developed as a novel class of drugs for the treatment of human diseases by targeted protein degradation. BOC Sciences will continue to investigate on this technique. We would be glad to hear from you and we’re looking forward to working with you.
Please find more PROTAC molecules on PROTAC.
While PROTAC technology has been a rising star in drug development in recent years, the technique is still facing some issues caused by relatively with high molecular weight, stability, toxicity, pharmacokinetics and bioavailability. By overcoming these limitations, PROTACs could be eventually developed as a novel class of drugs for the treatment of human diseases by targeted protein degradation. BOC Sciences will continue to investigate on this technique. We would be glad to hear from you and we’re looking forward to working with you.
Please find more PROTAC molecules on PROTAC.
